THE ROLE OF ANTIBODIES TO ELASTIN IN VARIOUS CLINICAL VARIANTS OF THE COURSE OF SYSTEMIC SCLERODERMA

被引：0
|
作者：
Korenskaya, E. G. [1 ]
Paramonova, O. V. [1 ]
Shilova, L. N. [1 ]
Korolik, O. D. [1 ]
机构：
[1] Volgograd State Med Univ, Volgograd, Russia
来源：
OSTEOPOROSIS INTERNATIONAL | 2021年 / 32卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P228
引用
收藏
页码：S165 / S166
页数：2
相关论文
共 50 条
  • [41] CENTROMERE ANTIBODIES AND ANTIBODIES AGAINST SCL-70 NUCLEOPROTEIN IN PROGRESSIVE SYSTEMIC SCLERODERMA
    MEURER, M
    SCHARF, A
    LUDERSCHMIDT, C
    BRAUNFALCO, O
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (01) : 8 - 14
  • [42] RELATIONSHIP OF CLINICAL COURSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS TO PRESENCE OF CIRCULATING LYMPHOCYTOTOXIC ANTIBODIES
    BUTLER, WT
    ROSSEN, RD
    SHAPR, JT
    MITTAL, KK
    GARD, DA
    LIDSKY, MD
    ARTHRITIS AND RHEUMATISM, 1972, 15 (03): : 231 - &
  • [43] SPONTANEOUS SEQUESTRATION OF THE DISTAL FINGER PHALANX IN PROGRESSIVE SYSTEMIC SCLERODERMA - CLINICAL COURSE UNDER ULTRAVIOLET BLOOD IRRADIATION
    WOLLINA, U
    KNOPF, B
    AKTUELLE RHEUMATOLOGIE, 1991, 16 (02) : 58 - 60
  • [44] ASSOCIATION OF HLA ANTIGENS WITH ANTI-SCL-70-ANTIBODIES AND CLINICAL MANIFESTATIONS OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    HIETARINTA, M
    ILONEN, J
    LASSILA, O
    HIETAHARJU, A
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (04): : 323 - 326
  • [45] Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance
    Sanna, G
    Bertolaccini, ML
    Mameli, A
    Hughes, GRV
    Khamashta, MA
    Mathieu, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1795 - 1796
  • [46] Clinical significance of antiphospholipid antibodies in Indian scleroderma patients
    R. Gupta
    M. M. Thabah
    S. Gupta
    S. Shankar
    A. Kumar
    Rheumatology International, 2009, 30 : 277 - 279
  • [47] Clinical significance of antiphospholipid antibodies in Indian scleroderma patients
    Gupta, R.
    Thabah, M. M.
    Gupta, S.
    Shankar, S.
    Kumar, A.
    RHEUMATOLOGY INTERNATIONAL, 2009, 30 (02) : 277 - 279
  • [48] Autoantibodies and Their Role in Scleroderma Clinical Care
    Robyn T. Domsic
    Thomas A. Medsger
    Current Treatment Options in Rheumatology, 2016, 2 (3) : 239 - 251
  • [49] Systemic sclerosis (scleroderma) and related disorders: clinical aspects
    Clements, PJ
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2000, 14 (01): : 1 - 16
  • [50] The role of endotelin-1 in a pathogeny of a systemic scleroderma
    Yatsyshyn, RI
    Neyko, YM
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 220 - 220
12345